Ligand Pharma (LGND) Tops Q1 EPS by 11c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 307.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $307.02 | 52 Week High | $139.79 | |||
| Open | $307.02 | 52 Week Low | $82.07 | |||
| Day High | $307.02 | P/E | 714.00 | |||
| Day Low | $307.02 | EPS | $0.43 | |||
| Volume | 3 | |||||
